Hepatitis C among blood donors: cascade of care and predictors of loss to follow-up

Imagem de Miniatura
Arquivos
art_MACHADO_Hepatitis_C_among_blood_donors_cascade_of_care_2017.PDF (222.58 KB)
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2017
DOI
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
REVISTA DE SAUDE PUBLICA
Autores
ABREU, Fatima Regina Marques
SANTANA, Rbia Anita Ferraz
Citação
REVISTA DE SAUDE PUBLICA, v.51, article ID 40, 8p, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVE: To investigate the HCV cascade of care and to identify the factors associated with loss or absence to follow-up of patients identified as infected with hepatitis C through blood donation. METHODS: Blood donors from 1994 to 2012, identified with positive anti-HCV by enzyme immunoassay and immunoblot tests were invited to participate in the study, through letters or phone calls. Patients who agreed to participate were interviewed and their blood samples were collected for further testing. The following variables were investigated: demographic data, data on comorbidities and history concerning monitoring of hepatitis C. Multiple regression analysis by Poisson regression model was used to investigate the factors associated with non-referral for consultation or loss of follow-up. RESULTS: Of the 2,952 HCV-infected blood donors, 22.8% agreed to participate: 394 (58.2%) male, median age 48 years old and 364 (53.8%) Caucasian. Of the 676 participants, 39.7% did not receive proper follow-up or treatment after diagnosis: 45 patients referred not to be aware they were infected, 61 did not seek medical attention and 163 started a follow-up program, but were non-adherent. The main reasons for inadequate follow-up were not understanding the need for medical care (71%) and health care access difficulties (14%). The variables showing a significant association with inadequate follow-up after multiple regression analysis were male gender (PR = 1.40; 95% CI 1.15-1.71), age under or equal to 50 years (PR = 1.36; 95% CI 1.12-1.65) and non-Caucasians (PR = 1.53; 95% CI 1.27-1.84). CONCLUSIONS: About 40.0% of patients did not receive appropriate follow-up. These data reinforce the need to establish strong links between primary care and reference centers and the need to improve access to specialists and treatments.
Palavras-chave
Blood Donors, Hepatitis C diagnosis, Lost to Follow-Up, Risk Factors, Cascade of Care
URI
https://observatorio.fm.usp.br/handle/OPI/20058
Referências
  1. Astell-Burt T, 2012, SOC SCI MED, V75, P240, DOI 10.1016/j.socscimed.2012.02.046
  2. Barocas JA, 2014, HARM REDUCT J, V11, DOI 10.1186/1477-7517-11-1
  3. Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21
  4. Boscarino JA, 2015, HEPATOLOGY, V61, P802, DOI 10.1002/hep.27422
  5. Bruggmann P, 2012, J VIRAL HEPATITIS, V19, P829, DOI 10.1111/jvh.12008
  6. Capuani L, 2014, CAD SAUDE PUBLICA, V30, P1623, DOI 10.1590/0102-311X00024914
  7. Coutinho Leticia M S, 2008, Rev. Saúde Pública, V42, P992, DOI 10.1590/s0034-89102008000600003
  8. Davies HTO, 1998, BRIT MED J, V316, P989
  9. Denniston MM, 2012, HEPATOLOGY, V55, P1652, DOI 10.1002/hep.25556
  10. Holmberg SD, 2013, NEW ENGL J MED, V368, P1859, DOI 10.1056/NEJMp1302973
  11. Jacobson IM, 2010, CLIN GASTROENTEROL H, V8, P1017, DOI 10.1016/j.cgh.2010.08.026
  12. Klevens RM, 2012, CLIN INFECT DIS, V55, pS3, DOI 10.1093/cid/cis393
  13. Linas BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097317
  14. McGowan CE, 2013, HEPATOLOGY, V57, P1325, DOI 10.1002/hep.26246
  15. Meyer JP, 2015, INT J DRUG POLICY, V26, P922, DOI 10.1016/j.drugpo.2015.05.002
  16. Mitruka K, 2014, MMWR-MORBID MORTAL W, V63, P393
  17. Papatheodoridis GV, 2014, LIVER INT, V34, P1452, DOI 10.1111/liv.12565
  18. Pereira LMMB, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-60
  19. Razavi H, 2014, J VIRAL HEPATITIS, V21, P34, DOI 10.1111/jvh.12248
  20. Searson G, 2014, LIVER INT, V34, P668, DOI 10.1111/liv.12467
  21. Shah HA, 2013, CLIN GASTROENTEROL H, V11, P922, DOI 10.1016/j.cgh.2013.04.024
  22. Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1
  23. Sundus A, 2013, J PAK MED ASSOC, V63, P1566
  24. Treloar C, 2013, CLIN INFECT DIS, V57, pS51, DOI 10.1093/cid/cit263
  25. Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506
  26. Wedemeyer H, 2014, J VIRAL HEPATITIS, V21, P60, DOI 10.1111/jvh.12249
  27. Yehia BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101554
  28. Younossi ZM, 2013, J VIRAL HEPATITIS, V20, P550, DOI 10.1111/jvh.12080
  29. Zeremski M, 2013, WORLD J GASTROENTERO, V19, P7846, DOI 10.3748/wjg.v19.i44.7846

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/07
Artigos e Materiais de Revistas Científicas - LIM/46
Artigos e Materiais de Revistas Científicas - LIM/52
Artigos e Materiais de Revistas Científicas - ODS/03
Carregar mais